Notice ID: 5173e2a5bb1a4ea2adaa69defcfc71f4Special Notice
6640--NOTICE OF INTENT TO SOLE SOURCE Nucleic Acid Testing - M2000 - Abbott Molecular HIV, HCV, HCV GT, SARS COV-2 See Description - Page 2
Archived on October 13, 2021. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 4:00 PM UTC−04:00
- Posted
- September 13, 2021
- Notice type
- Special Notice
Notice details
- Office
- 242-NETWORK CONTRACT OFFICE 02 (36C242)
- Place of performance
- Albany, NY, 12208
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C24221Q1477
- Notice ID
- 5173e2a5bb1a4ea2adaa69defcfc71f4
Description
This acquisition is conducted under the authority of the Multiple-Award Schedule Program (41 U.S.C. 152(3) and 40 U.S.C. 501). The Department of Veterans Affairs, Veterans Integrated Services Network (VISN) 2, Network Contracting Office 2, and the Department of Pathology & Laboratory Services at the Samuel S. Stratton VA Medical Center in Albany, NY anticipate a five-year (1 base plus 4 option years) firm-fixed price Blanket Purchase Agreement under the terms of the Federal Supply Schedule (FSS) listed below on a limited sources basis to Abbott Laboratories. The proposed action is to provide a Real-Time PCR nucleic acid analyzer to perform for nucleic acid detection testing for the Abbott Molecular M2000 for HIV, HCV, HCV genotyping and SARs CoV-2. Quantities are estimated and not guaranteed. Pricing is to include all consumables for a cost per reportable test. The requirement for this procurement action is as follows: HIV 96/kit; HCV 96/kit; HCV GT 24/kit;SARS COV-2 96/kit. AbbotT Molecular is the only vendor that offers Real-Time amplification and detection analyzer that provides automation for molecular diagnostics of HIV amplification, HCV, HCV genotyping and SARS CoV-2. The reagents are proprietary to Abbott Molecular and are not available from any other vendor. The reagents and consumables are proprietary and are only compatible with the equipment offered by Abbott Molecular M2000. This is a Brand Name Justification under the authority of FAR 8.405-6(a)(1)(B), Items Peculiar to One Manufacturer. Abbott Molecular is the only laboratory testing vendor that has the molecular testing for HCV Genotyping on the same platform with HCV, HIV and SARS Co-V-2. Any other brand is incompatible for use with this system. The Government s technical experts, including Supervisory Medical Technologists and Biomedical Engineers from the Stratton VA Medical Center, conducted market research using specific internet searches in various search engines and also conducted a detailed Federal Supply Schedule 66 III search to determine if another vendor s analyzer and reagents could potentially be used instead of those from the Abbott Molecular for the Albany laboratory s HIV, HCV, HCV genotyping and SARs CoV-2 testing requirements. Based on the totality of the market research conducted by the facility s technical experts, the laboratory concludes that only Abbott Molecular can meet all the testing requirements.
Award Overview
Possible prior contract
Inferred, not confirmedInferred, not confirmed. Matched by agency, NAICS, place of performance and end-date proximity. This is a candidate, not the contractor of record.
Contract end date
Feb 10, 2022
NAICS
334516
Agency
Department of Veterans Affairs
Dollar amounts are not shown for inferred matches because the link is heuristic. Open the award below to check it.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C24221Q1477- 3×Special NoticeCurrentSep 13, 2021
6640--NOTICE OF INTENT TO SOLE SOURCE Nucleic Acid Testing - M2000 - Abbott Molecular HIV, HCV, HCV GT, SARS COV-2 See Description - Page 2
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C24221Q1477
Archive Date
Oct 13, 2021
Office Address
ALBANY, NY, 12208